Cengild Medical Berhad (0243) — Cash Flow Reinvestment Rate
Cengild Medical Berhad (0243) has a Cash Flow Reinvestment Rate of 78.92x as of December 2025, reinvesting RM74.73 Million (capex RM36.98 Million plus investments RM37.75 Million) from operating cash flow of RM947.00K. See Cengild Medical Berhad free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cengild Medical Berhad Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Cengild Medical Berhad across 6 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Cengild Medical Berhad.
Annual Cash Flow Reinvestment Rate for Cengild Medical Berhad (2020–2025)
Year-by-year capital reinvestment analysis for Cengild Medical Berhad. See Cengild Medical Berhad financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.28x | RM52.68 Million | RM16.08 Million | RM37.26 Million | ▼ -48.3% |
| 2024 | 6.33x | RM81.91 Million | RM12.94 Million | RM15.73 Million | ▲ +65.1% |
| 2023 | 3.84x | RM52.78 Million | RM13.76 Million | RM2.13 Million | ▲ +11.3% |
| 2022 | 3.45x | RM48.43 Million | RM14.05 Million | RM427.67K | ▲ +1231.9% |
| 2021 | 0.26x | RM3.70 Million | RM14.30 Million | RM1.70 Million | ▲ +11.4% |
| 2020 | 0.23x | RM2.61 Million | RM11.24 Million | RM610.08K | — |